Surrey researchers Sign in
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 Delta icsA Delta ent Delta fep Delta stxA : HgR oral vaccine SC599 in healthy human adult volunteers
Journal article   Peer reviewed

Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 Delta icsA Delta ent Delta fep Delta stxA : HgR oral vaccine SC599 in healthy human adult volunteers

C Sadorge, A Ndiaye, N Beveridge, S Frazer, R Giemza, N Jolly, J Johnson, H Liddy, CA Cosgrove, P Allavena, …
VACCINE, Vol.26(7), pp.978-987
13/02/2008

Abstract

Science & Technology Life Sciences & Biomedicine Immunology Medicine Research & Experimental Research & Experimental Medicine IMMUNOLOGY MEDICINE RESEARCH & EXPERIMENTAL oral vaccine Shigella dysenteriae dysentery FLEXNERI 2A BACILLARY DYSENTERY CONJUGATE VACCINES ANTIMICROBIAL RESISTANCE ISRAELI VOLUNTEERS IFN-GAMMA IMMUNOGENICITY STRAIN CONSTRUCTION SAFETY
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000253580700014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy